These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31728688)

  • 1. Impact of PET/CT on clinical management in patients with cancer of unknown primary-a PET/CT registry study.
    Reinert CP; Sekler J; la Fougère C; Pfannenberg C; Gatidis S
    Eur Radiol; 2020 Mar; 30(3):1325-1333. PubMed ID: 31728688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of PET/CT on management of patients with esophageal cancer - results from a PET/CT registry study.
    Reinert CP; Sekler J; Gani C; Nikolaou K; la Fougère C; Pfannenberg C; Gatidis S
    Eur J Radiol; 2021 Mar; 136():109524. PubMed ID: 33434862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical review of the investigation and management of carcinoma of unknown primary in a single cancer network.
    Shaw PH; Adams R; Jordan C; Crosby TD
    Clin Oncol (R Coll Radiol); 2007 Feb; 19(1):87-95. PubMed ID: 17305260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of initial imaging with gallium-68 dotatate PET/CT on diagnosis and management of patients with neuroendocrine tumors.
    Crown A; Rocha FG; Raghu P; Lin B; Funk G; Alseidi A; Hubka M; Rosales J; Lee M; Kennecke H
    J Surg Oncol; 2020 Mar; 121(3):480-485. PubMed ID: 31853990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact on Patient Management of [18F]-Fluorodeoxyglucose-Positron Emission Tomography (PET) Used for Cancer Diagnosis: Analysis of Data From the National Oncologic PET Registry.
    Subramaniam RM; Shields AF; Sachedina A; Hanna L; Duan F; Siegel BA; Hillner BE
    Oncologist; 2016 Sep; 21(9):1079-84. PubMed ID: 27401896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography as an effective diagnostic workup in cervical metastasis of carcinoma from an unknown primary tumor.
    Zhao K; Luo XM; Zhou SH; Liu JH; Yan SX; Lu ZJ; Yang SY; Lin LL; Dong MJ
    Cancer Biother Radiopharm; 2012 Dec; 27(10):685-93. PubMed ID: 22834634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The added value of
    Kazmierczak PM; Rominger A; Wenter V; Spitzweg C; Auernhammer C; Angele MK; Rist C; Cyran CC
    Eur Radiol; 2017 Apr; 27(4):1676-1684. PubMed ID: 27436022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of 3,4-dihydroxy-6-18F-fluoro-L-phenylalanine PET/CT on managing patients with brain tumors: the referring physician's perspective.
    Walter F; Cloughesy T; Walter MA; Lai A; Nghiemphu P; Wagle N; Fueger B; Satyamurthy N; Phelps ME; Czernin J
    J Nucl Med; 2012 Mar; 53(3):393-8. PubMed ID: 22323780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practice-based evidence for the clinical benefit of PET/CT-results of the first oncologic PET/CT registry in Germany.
    Pfannenberg C; Gueckel B; Wang L; Gatidis S; Olthof SC; Vach W; Reimold M; la Fougere C; Nikolaou K; Martus P
    Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):54-64. PubMed ID: 30269155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of F18-fluorodeoxyglycose positron emission tomography/computed tomography on the management of resectable pancreatic tumours.
    Yao J; Gan G; Farlow D; Laurence JM; Hollands M; Richardson A; Pleass HC; Lam VW
    ANZ J Surg; 2012 Mar; 82(3):140-4. PubMed ID: 22510123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of 18FDG-PET/CT in the management and gross tumor volume definition for radiotherapy of head and neck cancer; single institution experiences based on long-term follow-up].
    Hideghéty K; Cserháti A; Besenyi Z; Zag L; Gaál S; Együd Z; Mózes P; Szántó E; Csenki M; Rusz O; Varga Z; Dobi Á; Maráz A; Pávics L; Lengyel Z
    Magy Onkol; 2015 Jun; 59(2):103-10. PubMed ID: 26035157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection rate of unknown primary tumour by using somatostatin receptor PET/CT in patients with metastatic neuroendocrine tumours: a meta-analysis.
    De Dosso S; Treglia G; Pascale M; Tamburello A; Santhanam P; Kroiss AS; Pereira Mestre R; Saletti P; Giovanella L
    Endocrine; 2019 Jun; 64(3):456-468. PubMed ID: 31004334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Most of the Intended Management Changes After
    Calais J; Czernin J; Eiber M; Fendler WP; Gartmann J; Heaney AP; Hendifar AE; Pisegna JR; Hecht JR; Wolin EM; Slavik R; Gupta P; Quon A; Schiepers C; Allen-Auerbach MS; Herrmann K
    J Nucl Med; 2017 Nov; 58(11):1793-1796. PubMed ID: 28473600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron Emission Tomography-Computed Tomography for Patients with Recurrent Colorectal Liver Metastases: Impact on Restaging and Treatment Planning.
    Viganò L; Lopci E; Costa G; Rodari M; Poretti D; Pedicini V; Solbiati L; Chiti A; Torzilli G
    Ann Surg Oncol; 2017 Apr; 24(4):1029-1036. PubMed ID: 27807727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Utility of PET-18FDG in primary tumor site in a patient with cerebral metastases].
    Suárez Fernández JP; Serna Macías JA; Domínguez Grande ML; Liaño H; Pozo MA; Maldonado Suárez A
    Rev Esp Med Nucl; 2005; 24(4):253. PubMed ID: 16122410
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of (18)F-FDG PET/CT for evaluation of metastatic mediastinal lymph nodes in patients with lung squamous-cell carcinoma or adenocarcinoma.
    Lu P; Sun Y; Sun Y; Yu L
    Lung Cancer; 2014 Jul; 85(1):53-8. PubMed ID: 24792334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. F-18-Dopa Positron Emission Tomography/Computed Tomography Is More Sensitive Than Whole-Body Magnetic Resonance Imaging for the Localization of Persistent/Recurrent Disease of Medullary Thyroid Cancer Patients.
    Terroir M; Caramella C; Borget I; Bidault S; Dromain C; El Farsaoui K; Deandreis D; Grimaldi S; Lumbroso J; Berdelou A; Hadoux J; Hescot S; Hartl D; Baudin E; Schlumberger M; Leboulleux S
    Thyroid; 2019 Oct; 29(10):1457-1464. PubMed ID: 31530235
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prognostic value of PET/CT in lung cancer: retrospective analysis of 47 patients].
    de Guevara DL; Fuentes A; Fariña C; Corral C; Pefaur R
    Rev Med Chil; 2013 Jan; 141(1):41-8. PubMed ID: 23732413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of 18-Fludeoxyglucose positron emission tomography-computed tomography and subsequent panendoscopy in head and neck squamous cell carcinoma of unknown primary.
    Mani N; George MM; Nash L; Anwar B; Homer JJ
    Laryngoscope; 2016 Jun; 126(6):1354-8. PubMed ID: 26671043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with
    Sampathirao N; Basu S
    J Nucl Med Technol; 2017 Mar; 45(1):34-41. PubMed ID: 28154019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.